RxDoctor Payments Data

Therese Rinaldi, DPM

Podiatrist · Pottstown, PANPI 1548212061

Payments from drug & device makers

$1,236in general payments, 2019–2025

Across 53 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$416
  • Averitas Pharma Inc.$288
  • AbbVie$114
  • Paratek Pharmaceuticals, Inc.$67
  • Convatec Inc.$63
  • Amgen$55
  • plus $233 from 7 others

What the payments were for

  • Food & beverage$1,236100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.15$416
Averitas Pharma Inc.9$288
AbbVie6$114
Paratek Pharmaceuticals, Inc.4$67
Convatec Inc.3$63
Amgen4$55
Nevro Corp.3$52
Smith+Nephew3$51
Zimmer Biomet1$33
Cashflow Solutions, LLC1$31
GRT US Holding, Inc.2$29
Vertex1$19
Synergy Orthopedics, LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,236 in reported general payments places this provider in the 60th percentile of 445 podiatrist providers in Pennsylvania.

See all podiatrist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$335,411
Medicare patients
501
Services billed
28,535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin16$600
Terbinafine Hcl62$506
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$139
Clindamycin Hcl15$113
Naproxen24$77
Prednisone14$44

Paid to pharmacies, not to this prescriber.

Other podiatrist in Pottstown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →